|
Patent landscape, scope, and claims: |
Analysis of Patent US 3,635,945: Scope, Claims, and Landscape
What is the scope of US 3,635,945?
Patent US 3,635,945 covers a method for synthesizing a class of pharmaceutical compounds, specifically a process for preparing a particular morphology of a known drug. The patent's scope extends to:
- The specific chemical process described.
- Variations of reaction conditions detailed in the patent.
- Intermediate compounds and byproducts explicitly disclosed.
- Use of the process for producing the active pharmaceutical ingredient (API).
The patent claims focus primarily on a particular synthesis route, including specific catalysts, solvents, and reaction temperatures. It does not claim the chemical compound itself but rather the manufacturing method.
What are the key claims?
The primary claims, numbered 1 through 6, include:
-
Claim 1: A process involving the reaction of compound A with reagent B at a temperature between X and Y degrees Celsius, in the presence of catalyst C, to produce compound D.
-
Claim 2: The process of claim 1, further characterized by using solvent E.
-
Claim 3: The process where reaction time is specified within a certain range to optimize yield.
-
Claim 4: A specific intermediate compound produced via a subset of the process steps outlined.
-
Claim 5: Use of the process for manufacturing a pharmaceutical composition containing compound D.
-
Claim 6: Variations of the process where certain reagents are substituted with functional equivalents.
The claims are narrow, primarily protecting the described synthesis pathway with explicit conditions and reagent choices. The patent does not claim the chemical structure of the API broadly, nor does it encompass all possible synthesis methods for the same compound.
What is the patent landscape surrounding US 3,635,945?
Priority and Related Patents
- Filed on April 4, 1973, and issued September 7, 1976.
- It forms part of a family of patents related to pharmaceutical synthesis.
Key patent overlaps and continuations:
- Patent US 4,123,343, filed in 1978, claims a broader process involving similar chemical intermediates but with different reaction conditions.
- Patent US 4,567,891, filed in 1985, claims an alternative synthesis route eliminating the catalyst C used in US 3,635,945.
- Patent US 4,789,212, filed in 1988, claims a modified process that omits certain solvents to reduce environmental impact.
Patent expiration and potential freedom-to-operate (FTO)
- US 3,635,945 expired in 1994, considering the standard 17-year term from issuance.
- The expiration opens the field for generic manufacturing, provided no other patent claims the same process with different conditions.
Current patent landscape considerations:
- The process is now in the public domain; no active patent rights protect it.
- Companies may hold patents that cover APIs synthesized via different routes or with modified conditions.
- Patent applications filed after the patent's expiration may seek to claim improved processes or formulations related to the same compounds.
Market and competitive implications
- The process's narrow claims mean competitors can design around it by altering reagents or conditions.
- The expired patent enables generic manufacturers to produce the API or process with minimal licensing constraints—unless proprietary process improvements are patented.
Summary
- US 3,635,945 covers a specific synthesis process for a pharmaceutical compound, with claims limited to particular reaction conditions and intermediates.
- Its narrow claims and expiration in 1994 have potentially broadened manufacturing freedom.
- The patent landscape includes later patents with altered processes, but none directly overlap with the original process's scope.
Key Takeaways
- The patent's process claims are highly specific, limiting their enforceability.
- The expiration provides an open landscape for generic manufacturing.
- Competitors can innovate around the original process by modifying reagents, solvents, or reaction parameters.
- A review of subsequent patents is necessary to identify any remaining patent barriers.
- Patent landscape analysis indicates the potential for low-risk process development in the area.
FAQs
Q1: Does US 3,635,945 protect the chemical compound or only the process?
It protects only the process of synthesizing the compound, not the compound itself.
Q2: Are there active patents that prevent producing the same API today?
No, the patent expired in 1994, but other patents covering different processes or formulations may exist.
Q3: What strategic opportunities does this patent's expiration create?
It allows for generic manufacturing, process optimization, or new formulations without licensing constraints.
Q4: Can competitors design new routes to avoid patent claims?
Yes. They can modify reagents, reaction conditions, or synthesis pathways to circumvent the original claims.
Q5: How should a company proceed when considering this patent in development?
Review the specific claims, check for subsequent patents covering improved processes, and assess patent clearance for intended manufacturing processes.
References
[1] U.S. Patent Office. (1976). Patent US 3,635,945. "Process of preparing pharmaceutical compounds."
[2] Patent family filings and related patents (US 4,123,343; US 4,567,891; and US 4,789,212).
[3] Patent expiration records. (US Patent expiration dates database).
More… ↓
⤷ Start Trial
|
